Kalaris Therapeutics Inc.

NASDAQ: KLRS
Share price (3/21/25): $11.00
Market cap (3/21/25): $206 million

Warning: Large portions of this site require JavaScript enabled in order to function properly. Please make sure JavaScript is enabled in your browser.

Please let us know at support@bamsec.com if you have any questions or concerns.

Search in Documents

Key Exhibits

External Links

Financials Filter

ended 12/31/24 FY 2024

ended 09/30/24 Q3

ended 06/30/24 Q2

ended 03/31/24 Q1

ended 12/31/23 FY 2023

Prospectuses and Registrations Filter

Prospectus supplement

Prospectus supplement

Details of business combination or exchange offer – amended

Details of business combination or exchange offer – amended

Business combination disclosure

Ownership Filter

Gilead Sciences Inc.

Ferrara Napoleone

Patel Samir Chandrakant

Feinsod Matthew

News Filter

Announces Closing of Merger With AlloVir

Kalaris and AlloVir Announce Stockholder Approval of Merger

Material Modification to Rights of Security Holders, Amendment to Articles of Incorporation or Bylaws, or Change in Fiscal Year, Financial Statements or Exhibits

Shareholder Vote Results

Proxies Filter

Definitive proxy

Preliminary proxy

Additional info about upcoming vote

Definitive proxy

Additional info about upcoming vote

Other Filter

SEC STAFF LETTER

Notice of effectiveness

Correspondence with the SEC

Correspondence with the SEC

Letter from the SEC